Junwei Zou

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Endoplasmic Reticulum Stress

Cell Proliferation

Endoscopic Submucosal Dissection

Top Venues

Journal of oncology

Cancer biotherapy & radiopharmaceuticals

Analytical cellular pathology (Amsterdam)

This page only lists publications with an associated author ORCID identifier.

Publications

Siyuan Zuo, Yong Huang, Junwei Zou
The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer. IUBMB life (2024)
Junwei Zou, Yong Huang, Yuan Chen, Zhaoying Wu, Hao Xie, Hailang Zhou, Chungen Xing
FOXC2-induced circCASK aggravates colorectal cancer progression by upregulating SIX1 expression. IUBMB life (2023)
Junwei Zou, Zhenhan Li, Jiaheng Xie, Zhaoying Wu, Yujin Huang, Hao Xie, Huiqiu Xu, Yong Huang, Hailang Zhou
Methylation Drives SLC2A1 Transcription and Ferroptosis Process Decreasing Autophagy Pressure in Colon Cancer. Journal of oncology 2022 (2022)
Hailang Zhou, Shu Huang, Changjiang Shao, Junwei Zou, Aijun Zhou, Jiufeng Yu, Chunfang Xu
miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3. Analytical cellular pathology (Amsterdam) 2022 (2022)
Xiuhua Shi, Junwei Zou, Yinhua Wang, Jian Zhao, Bin Ye, Qinghua Qi, Fei Liu, Jun Hu, Shu Li, Ye Tian
MST4 as a novel therapeutic target for autophagy and radiosensitivity in gastric cancer. IUBMB life (2022)
Junwei Zou, Hesong Zhang, Zhaoying Wu, Weichao Hu, Tingting Zhang, Hao Xie, Yong Huang, Hailang Zhou
TIGD1 Is an Independent Prognostic Factor that Promotes the Progression of Colon Cancer. Cancer biotherapy & radiopharmaceuticals (2022)
Yong Huang, Hailang Zhou, Junwei Zou, Dong Wang
GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma. Canadian journal of gastroenterology & hepatology 2022 (2022)